Peter Wijngaard - May 18, 2021 Form 4 Insider Report for Hepion Pharmaceuticals, Inc. (HEPA)

Role
Director
Signature
/s/ Peter Wijngaard
Stock symbol
HEPA
Transactions as of
May 18, 2021
Transactions value $
$0
Form type
4
Date filed
5/20/2021, 04:37 PM
Next filing
Sep 20, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HEPA Stock Options Award $0 +200K +333.33% $0.00 260K May 18, 2021 Common Stock 200K $1.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan.